BenzingaSeptember 14, 2026 at 1:03 PM NYLast Month
PharmaCyte Biotech Q1 EPS $(0.54) Up From $(1.23) YoY, Sales $0.00, Same YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(0.54) per share. This is a 56.1 percent increase over losses of $(1.23) per share from the same period last year. The company reported $0.00 in sales this
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
